On the other hand, it has been shown that the prevalence and severity of anemia are related to IBD activity and treatments used to attenuate the IBD-associated mucosal inflammation (i.e., TNF blockers) can improve ACD [9,10,11]. The gene discussed is TNF; the disease is inflammatory bowel disease.